Recursion Pharmaceuticals, Inc.RXRXNASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank0
3Y CAGR-10.4%
5Y CAGR-51.1%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
-10.4%/yr
Annual compound
5Y CAGR
-51.1%/yr
Recent acceleration
Percentile
P0
Near historical low
vs 5Y Ago
0x
Contraction
Streak
2 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 24.50 | -22.2% |
| 2024 | 31.50 | -32.6% |
| 2023 | 46.71 | +37.0% |
| 2022 | 34.11 | -88.3% |
| 2021 | 291.68 | -66.6% |
| 2020 | 874.38 | -49.9% |
| 2019 | 1744.15 | - |